Brand name: Lucentis
Ranibizumab is a medicine to treat neovascular age-related macular degeneration.
It refers to monoclonal antibodies. It reduces the eye cells growth. It protects the eye blood vessels from leakage and reduces new blood vessels formation in the eye.